Review began 11/30/2022 review ended 02/04/2023 published 02/19/2023 © copyright

HIGHLIGHTS

• who: Dopamine Agonist-Resistant Prolactinomas A and colleagues from the (UNIVERSITY) have published the article: Review began 11/30/2022 Review ended 02/04/2023 Published 02/19/2023 u00a9 Copyright, in the Journal: (JOURNAL) of February/19,/2023
• what: The aim of this paper is to perform systematic review of the role of tamoxifen in the treatment of systematic review was conducted. A total of six cases were excluded for the following reasons: The results from this study showed that four of 22 patients had stability, regression of tumor size, and resolution of a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.